On the face of it a tally of 29 victories in their first WorldTour season should be marked down as a major success for Iwan Spekenbrink and his Argos-Shimano team. Marcel Kittel was the undoubted star ...
Immunotherapy company Argos Therapeutics has filed plans for a $60 million initial public stock offering to finance late-stage clinical trials on its experimental kidney cancer treatment. It’s the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results